Literature DB >> 18501702

P2X7 receptor as sensitive flow sensor for ERK activation in osteoblasts.

Hisashi Okumura1, Dai Shiba, Toshikazu Kubo, Takahiko Yokoyama.   

Abstract

The involvement of the P2 receptor in the activation of ERK induced by a short transient fluid flow stimulation in MC3T3-E1 osteoblasts was examined in the current study. The ERK activation induced by this transient fluid flow stimulation was followed by an increase in c-fos mRNA expression. Suramin, a non-selective P2 receptor antagonist, and two different P2X7 receptor (P2X7R) antagonists, ATP analogue (oxidized ATP) and dye (Brilliant blue G), inhibited fluid flow-induced ERK activation. However, the P2Y receptor pathway inhibitor U73122 did not abolish this ERK activation. The P2X7R agonist 2',3'-O-(4-benzoylbenzoyl)-ATP (BzATP) significantly increased ERK activation and this activation could be completely inhibited by oxidized ATP and Brilliant blue G. Our results suggest that P2X7R is a highly sensitive P2 receptor for fluid flow-induced ERK activation in osteoblasts.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18501702     DOI: 10.1016/j.bbrc.2008.05.066

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

1.  Inhibition of the P2X7 receptor reduces cystogenesis in PKD.

Authors:  Ming-Yang Chang; Jenn-Kan Lu; Ya-Chung Tian; Yung-Chang Chen; Cheng-Chieh Hung; Yi-Hui Huang; Yau-Hung Chen; Mai-Szu Wu; Chih-Wei Yang; Yi-Chuan Cheng
Journal:  J Am Soc Nephrol       Date:  2011-06-02       Impact factor: 10.121

Review 2.  Purinergic signalling in the musculoskeletal system.

Authors:  Geoffrey Burnstock; Timothy R Arnett; Isabel R Orriss
Journal:  Purinergic Signal       Date:  2013-08-14       Impact factor: 3.765

3.  Receptor-independent effects of 2'(3')-O-(4-benzoylbenzoyl)ATP triethylammonium salt on cytosolic pH.

Authors:  Juan Pablo Reyes; Matthew W Grol; Stephen M Sims; S Jeffrey Dixon
Journal:  Purinergic Signal       Date:  2013-05-22       Impact factor: 3.765

4.  Expression, signaling, and function of P2X7 receptors in bone.

Authors:  Matthew W Grol; Nattapon Panupinthu; Jasminka Korcok; Stephen M Sims; S Jeffrey Dixon
Journal:  Purinergic Signal       Date:  2009-02-18       Impact factor: 3.765

Review 5.  P2X7Rs: new therapeutic targets for osteoporosis.

Authors:  Haoyun Huang; Yu-Mei He; Miao-Miao Lin; Yanchao Wang; Xiaomei Zhang; Li Liang; Xueling He
Journal:  Purinergic Signal       Date:  2022-02-02       Impact factor: 3.765

6.  P2X7 Receptor Function in Bone-Related Cancer.

Authors:  Elena Adinolfi; Francesca Amoroso; Anna Lisa Giuliani
Journal:  J Osteoporos       Date:  2012-08-16

7.  The roles of P2Y2 purinergic receptors in osteoblasts and mechanotransduction.

Authors:  Yanghui Xing; Yan Gu; James J Bresnahan; Emmanuel M Paul; Henry J Donahue; Jun You
Journal:  PLoS One       Date:  2014-09-30       Impact factor: 3.240

8.  Emerging key roles for P2X receptors in the kidney.

Authors:  R E Birch; E M Schwiebert; C M Peppiatt-Wildman; S S Wildman
Journal:  Front Physiol       Date:  2013-09-27       Impact factor: 4.566

Review 9.  The P2X7 receptor: a key player in immune-mediated bone loss?

Authors:  Torben Madsen Kvist; Peter Schwarz; Niklas Rye Jørgensen
Journal:  ScientificWorldJournal       Date:  2014-01-16

10.  Trophic activity of human P2X7 receptor isoforms A and B in osteosarcoma.

Authors:  Anna Lisa Giuliani; Davide Colognesi; Tiziana Ricco; Carlotta Roncato; Marina Capece; Francesca Amoroso; Qi Guang Wang; Elena De Marchi; Allison Gartland; Francesco Di Virgilio; Elena Adinolfi
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.